Showing results (351-360 of 477) with videos related to
Sort By:
Pageof 48
Frontiers in Oncology|June 6, 2019
Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients-First Clinical Results From a Single CenterLaila König, Kristin Lang, Jörg Heil, et al.Molecules (Basel, Switzerland)|December 23, 2017
Synthesis, Crystal Structure, and Supramolecular Understanding of 1,3,5-Tris(1-phenyl-1H-pyrazol-5-yl)benzenesMarcos A P Martins, Alexandre R Meyer, Paulo R S Salbego, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 2021
Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomesFabian Weykamp, Charlotte Herder-Wagner, Sebastian Regnery, et al.Frontiers in Oncology|February 19, 2026
Long-term patient experience with online MR-guided radiotherapy: adaptive versus non-adaptive workflowFabian Weykamp, Charlotte Herder-Wagner, Sebastian Regnery, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 10, 2025
Radiation Oncology Representation in German Evidence-Based Oncological Guidelines: 2025 Analysis of Participation and Parity from Women in Radiation Oncology Working Group of the German Society of Radiation Oncology (DEGRO)Angela Besserer, Sally Mutiara, Monika Nothacker, et al.Cancers|May 14, 2025
Intrafractional Motion in Online-Adaptive Magnetic Resonance-Guided Radiotherapy of Adrenal Metastases Leads to Reduced Target Volume Coverage and Elevated Organ-at-Risk DosesPhilipp Hoegen-Saßmannshausen, Tobias P Hartschuh, Claudia Katharina Renkamp, et al.Cancers|December 17, 2024
Hematologic Toxicity Profiles and the Impact of Hemoglobin Nadir and Transfusion on Oncologic Outcome in Definitive Radiochemotherapy for Cervical CancerEva Meixner, Laura Wermes, Line Hoeltgen, et al.Cancers|April 23, 2022
Outcome after Radiotherapy for Vestibular Schwannomas (VS)-Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton TherapyMaike Küchler, Rami A El Shafie, Sebastian Adeberg, et al.Cancer Management and Research|December 18, 2018
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapyDenise Bernhardt, Sophie Aufderstrasse, Laila König, et al.Journal of Translational Medicine|June 4, 2026
Inverse relationship between neoantigen clonality and T-cell activity reveals distinct immune phenotypes in HNSCCBabak Saravi, Daman Deep Singh, Lara Schorn, et al.Pageof 48